1-6 of 260 Activities
In this CME Outfitters live Q&A, expert faculty will answer questions about the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
In this CME Outfitters livestream symposium, expert faculty will guide learners on the implementation of routine HIV testing and on adopting a status-neutral approach to effectively promote prevention strategies and PrEP initiation. Faculty will evaluate current and emerging PrEP options, introduce emerging LAI PrEP options, and discuss optimal patient selection criteria, transitioning strategies, and monitoring considerations. Faculty will model integration of effective patient engagement strategies to collaboratively initiate PrEP treatment and support adherence.
In this CME Outfitters live webcast, expert faculty will examine socioeconomic, geographic, and systemic factors that contribute to disparities in clinical trial access, particularly in underserved or community-based settings. Faculty will help learners identify interprofessional strategies, including use of culturally responsive communication, patient navigators, and advocacy partnerships, to engage underrepresented patients in clinical trial discussions and enrollment.
In this CME Outfitters Webcast, expert faculty will discuss strategies for identifying the physiologic biopsychosocial factors that influence pain, utilizing pain assessment tools that reinforce approaches to the appropriate management of pain, implementing strategies from the 2022 CDC Guideline for Prescribing Opioids into the development of safe and effective pain management plans, and other valuable skills for improving the treatment of patients suffering from chronic pain.
In the fifth activity of this CME Outfitters Snack series, expert faculty will assess dosing strategies and escalation best practices to optimize patient outcomes and foster therapy adherence. Faculty will model development of patient-centered counseling strategies that address concerns or misconceptions of GLP-1 RA therapies, including evidence-based benefits.
Clinicians also frequently overlook the additive ASCVD risk of elevated lipoprotein(a) [Lp(a)], despite its independent, genetically determined role in atherosclerosis and the growing body of data supporting one-time screening and targeted therapy. New therapies in development, including siRNA and antisense oligonucleotides, further complicate treatment decisions and highlight the need for timely, expert-led education. In this CME Outfitters recorded webcast, expert faculty will propose a curriculum that combats inertia by dispelling persistent myths, clarifying evidence-based strategies, and empowering clinicians to implement current and emerging therapies in everyday practice to improve lipid outcomes and reduce ASCVD-related morbidity and mortality.
In this CME Outfitters BriefCase, expert faculty will use case examples to highlight the current clinical guidelines for biomarker testing and advise learners on addressing ethnic, geographic, and socioeconomic barriers to optimal utilization of biomarker testing in lung cancer.
